{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:29:24Z","timestamp":1792466964617,"version":"4.5.0"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76731-w","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T11:44:16Z","timestamp":1786621456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Single-component self-assembling protein nanoparticles displaying stabilized prefusion-closed hemagglutinin trimers for influenza vaccine development"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9053-5890","authenticated-orcid":false,"given":"Yi-Nan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-3740","authenticated-orcid":false,"given":"Xueyong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keegan","family":"Braz Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5651-863X","authenticated-orcid":false,"given":"Yi-Zong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"DesRoberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6469-2419","authenticated-orcid":false,"given":"Ian A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0259-7157","authenticated-orcid":false,"given":"Jiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"76731_CR1","unstructured":"World Health Organization (WHO) Fact Sheets\u2014Influenza (seasonal): https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal)."},{"key":"76731_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","volume":"4","author":"F Krammer","year":"2018","unstructured":"Krammer, F. et al. Influenza. Nat. Rev. Dis. Prim. 4, 3 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"76731_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","volume":"390","author":"C Paules","year":"2017","unstructured":"Paules, C. & Subbarao, K. Influenza. Lancet 390, 697\u2013708 (2017).","journal-title":"Lancet"},{"key":"76731_CR4","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1038\/nm1141","volume":"10","author":"P Palese","year":"2004","unstructured":"Palese, P. Influenza: old and new threats. Nat. Med. 10, S82\u2013S87 (2004).","journal-title":"Nat. Med."},{"key":"76731_CR5","doi-asserted-by":"crossref","unstructured":"Wolff, T. & Veit, M. Influenza B, C and D viruses (Orthomyxoviridae). Encycl. Virol. 2, 561\u2013574 (2021).","DOI":"10.1016\/B978-0-12-809633-8.21505-7"},{"key":"76731_CR6","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","volume":"391","author":"AD Iuliano","year":"2018","unstructured":"Iuliano, A. D. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285\u20131300 (2018).","journal-title":"Lancet"},{"key":"76731_CR7","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJMra1208802","volume":"370","author":"HV Fineberg","year":"2014","unstructured":"Fineberg, H. V. Pandemic preparedness and response\u2014lessons from the H1N1 influenza of 2009. N. Engl. J. Med. 370, 1335\u20131342 (2014).","journal-title":"N. Engl. J. Med."},{"key":"76731_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/v10090461","volume":"10","author":"TC Sutton","year":"2018","unstructured":"Sutton, T. C. The pandemic threat of emerging H5 and H7 avian influenza viruses. Viruses 10, 461 (2018).","journal-title":"Viruses"},{"key":"76731_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","volume":"69","author":"JJ Skehel","year":"2000","unstructured":"Skehel, J. J. & Wiley, D. C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531\u2013569 (2000).","journal-title":"Annu. Rev. Biochem."},{"key":"76731_CR10","doi-asserted-by":"publisher","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","volume":"285","author":"SJ Gamblin","year":"2010","unstructured":"Gamblin, S. J. & Skehel, J. J. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J. Biol. Chem. 285, 28403\u201328409 (2010).","journal-title":"J. Biol. Chem."},{"key":"76731_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fmicb.2019.00039","volume":"10","author":"JL McAuley","year":"2019","unstructured":"McAuley, J. L., Gilbertson, B. P., Trifkovic, S., Brown, L. E. & McKimm-Breschkin, J. L. Influenza virus neuraminidase structure and functions. Front. Microbiol. 10, 39 (2019).","journal-title":"Front. Microbiol."},{"key":"76731_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/rmv.352","volume":"12","author":"R Wagner","year":"2002","unstructured":"Wagner, R., Matrosovich, M. & Klenk, H. D. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol. 12, 159\u2013166 (2002).","journal-title":"Rev. Med. Virol."},{"key":"76731_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/v11040346","volume":"11","author":"I Kosik","year":"2019","unstructured":"Kosik, I. & Yewdell, J. W. Influenza hemagglutinin and neuraminidase: Yin-Yang proteins coevolving to thwart immunity. Viruses 11, 346 (2019).","journal-title":"Viruses"},{"key":"76731_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/v11050458","volume":"11","author":"RK Du","year":"2019","unstructured":"Du, R. K., Cui, Q. H. & Rong, L. J. Competitive cooperation of hemagglutinin and neuraminidase during influenza A virus entry. Viruses 11, 458 (2019).","journal-title":"Viruses"},{"key":"76731_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tim.2019.08.010","volume":"28","author":"E de Vries","year":"2020","unstructured":"de Vries, E., Du, W., Guo, H. & de Haan, C. A. M. Influenza A virus hemagglutinin-neuraminidase-receptor balance: Preserving virus motility. Trends Microbiol. 28, 57\u201367 (2020).","journal-title":"Trends Microbiol."},{"key":"76731_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/07391102.2018.1436089","volume":"37","author":"LV Kordyukova","year":"2019","unstructured":"Kordyukova, L. V., Shtykova, E. V., Baratova, L. A., Svergun, D. I. & Batishchev, O. V. Matrix proteins of enveloped viruses: a case study of Influenza A virus M1 protein. J. Biomol. Struct. Dyn. 37, 671\u2013690 (2019).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"76731_CR17","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3390\/cells8070654","volume":"8","author":"J To","year":"2019","unstructured":"To, J. & Torres, J. Viroporins in the influenza virus. Cells 8, 654 (2019).","journal-title":"Cells"},{"key":"76731_CR18","doi-asserted-by":"publisher","first-page":"a038505","DOI":"10.1101\/cshperspect.a038505","volume":"10","author":"RA Lamb","year":"2020","unstructured":"Lamb, R. A. The structure, function, and pathobiology of the influenza A and B virus ion channels. Cold Spring Harb. Perspect. Med. 10, a038505 (2020).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"76731_CR19","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3389\/fimmu.2018.01581","volume":"9","author":"D Dou","year":"2018","unstructured":"Dou, D., Revol, R., Ostbye, H., Wang, H. & Daniels, R. Influenza A virus cell entry, replication, virion assembly and movement. Front. Immunol. 9, 1581 (2018).","journal-title":"Front. Immunol."},{"key":"76731_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2225645","volume":"12","author":"S Fereidouni","year":"2023","unstructured":"Fereidouni, S. et al. Genetic characterization of a new candidate hemagglutinin subtype of influenza A viruses. Emerg. Microbes Infect. 12, 2225645 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"76731_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/rmv.319","volume":"11","author":"MC Zambon","year":"2001","unstructured":"Zambon, M. C. The pathogenesis of influenza in humans. Rev. Med. Virol. 11, 227\u2013241 (2001).","journal-title":"Rev. Med. Virol."},{"key":"76731_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(24)00066-1","volume":"5","author":"S Caini","year":"2024","unstructured":"Caini, S. et al. Probable extinction of influenza B\/Yamagata and its public health implications: a systematic literature review and assessment of global surveillance databases. Lancet Microbe 5, 100851 (2024).","journal-title":"Lancet Microbe"},{"key":"76731_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/archinte.165.3.265","volume":"165","author":"L Simonsen","year":"2005","unstructured":"Simonsen, L. et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch. Intern. Med. 165, 265\u2013272 (2005).","journal-title":"Arch. Intern. Med."},{"key":"76731_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.vaccine.2012.10.084","volume":"31","author":"CA DiazGranados","year":"2012","unstructured":"DiazGranados, C. A., Denis, M. & Plotkin, S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 31, 49\u201357 (2012).","journal-title":"Vaccine"},{"key":"76731_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126274","volume":"42","author":"S Goldin","year":"2024","unstructured":"Goldin, S. et al. Seasonal influenza vaccination: a global review of national policies in 194 WHO member states in 2022. Vaccine 42, 126274 (2024).","journal-title":"Vaccine"},{"key":"76731_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.15585\/mmwr.mm7432a2","volume":"74","author":"LA Grohskopf","year":"2025","unstructured":"Grohskopf, L. A. et al. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices\u2014United States, 2025-26 influenza season. MMWR Morb. Mortal. Wkly. Rep. 74, 500\u2013507 (2025).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"76731_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.coviro.2014.02.008","volume":"6","author":"H Jin","year":"2014","unstructured":"Jin, H. & Chen, Z. Production of live attenuated influenza vaccines against seasonal and potential pandemic influenza viruses. Curr. Opin. Virol. 6, 34\u201339 (2014).","journal-title":"Curr. Opin. Virol."},{"key":"76731_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150700","volume":"11","author":"TC Kon","year":"2016","unstructured":"Kon, T. C. et al. Influenza vaccine manufacturing: effect of inactivation, splitting and site of manufacturing. Comparison of influenza vaccine production processes. PLoS ONE 11, e0150700 (2016).","journal-title":"PLoS ONE"},{"key":"76731_CR29","doi-asserted-by":"publisher","first-page":"711997","DOI":"10.3389\/fimmu.2021.711997","volume":"12","author":"JD Chen","year":"2021","unstructured":"Chen, J. D., Wang, J. H., Zhang, J. P. & Ly, H. Advances in development and application of influenza vaccines. Front. Immunol. 12, 711997 (2021).","journal-title":"Front. Immunol."},{"key":"76731_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2243","volume":"32","author":"YH Kim","year":"2022","unstructured":"Kim, Y. H., Hong, K. J., Kim, H. & Nam, J. H. Influenza vaccines: past, present, and future. Rev. Med. Virol. 32, e2243 (2022).","journal-title":"Rev. Med. Virol."},{"key":"76731_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/vim.2017.0141","volume":"31","author":"H Kim","year":"2018","unstructured":"Kim, H., Webster, R. G. & Webby, R. J. Influenza virus: dealing with a drifting and shifting pathogen. Viral Immunol. 31, 174\u2013183 (2018).","journal-title":"Viral Immunol."},{"key":"76731_CR32","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature01509","volume":"422","author":"NM Ferguson","year":"2003","unstructured":"Ferguson, N. M., Galvani, A. P. & Bush, R. M. Ecological and immunological determinants of influenza evolution. Nature 422, 428\u2013433 (2003).","journal-title":"Nature"},{"key":"76731_CR33","doi-asserted-by":"publisher","first-page":"6852","DOI":"10.1016\/j.vaccine.2007.07.027","volume":"25","author":"F Carrat","year":"2007","unstructured":"Carrat, F. & Flahault, A. Influenza vaccine: the challenge of antigenic drift. Vaccine 25, 6852\u20136862 (2007).","journal-title":"Vaccine"},{"key":"76731_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/vaccines6020019","volume":"6","author":"AT Harding","year":"2018","unstructured":"Harding, A. T. & Heaton, N. S. Efforts to improve the seasonal influenza vaccine. Vaccines 6, 19 (2018).","journal-title":"Vaccines"},{"key":"76731_CR35","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev.bi.56.070187.002053","volume":"56","author":"DC Wiley","year":"1987","unstructured":"Wiley, D. C. & Skehel, J. J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56, 365\u2013394 (1987).","journal-title":"Annu. Rev. Biochem."},{"key":"76731_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fimmu.2018.00320","volume":"9","author":"XY Chen","year":"2018","unstructured":"Chen, X. Y. et al. Host immune response to influenza A virus infection. Front. Immunol. 9, 320 (2018).","journal-title":"Front. Immunol."},{"key":"76731_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19, 383\u2013397 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"76731_CR38","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.antiviral.2013.03.021","volume":"98","author":"NS Laursen","year":"2013","unstructured":"Laursen, N. S. & Wilson, I. A. Broadly neutralizing antibodies against influenza viruses. Antivir. Res. 98, 476\u2013483 (2013).","journal-title":"Antivir. Res."},{"key":"76731_CR39","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1749-6632.2010.05829.x","volume":"1217","author":"T Han","year":"2011","unstructured":"Han, T. & Marasco, W. A. Structural basis of influenza virus neutralization. Ann. N. Y. Acad. Sci. 1217, 178\u2013190 (2011).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"76731_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.coviro.2017.03.002","volume":"24","author":"D Corti","year":"2017","unstructured":"Corti, D. et al. Tackling influenza with broadly neutralizing antibodies. Curr. Opin. Virol. 24, 60\u201369 (2017).","journal-title":"Curr. Opin. Virol."},{"key":"76731_CR41","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.jmb.2017.06.015","volume":"429","author":"NC Wu","year":"2017","unstructured":"Wu, N. C. & Wilson, I. A. A perspective on the structural and functional constraints for immune evasion: Insights from influenza virus. J. Mol. Biol. 429, 2694\u20132709 (2017).","journal-title":"J. Mol. Biol."},{"key":"76731_CR42","doi-asserted-by":"publisher","first-page":"a038778","DOI":"10.1101\/cshperspect.a038778","volume":"10","author":"NC Wu","year":"2020","unstructured":"Wu, N. C. & Wilson, I. A. Influenza hemagglutinin structures and antibody recognition. Cold Spring Harb. Perspect. Med. 10, a038778 (2020).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"76731_CR43","doi-asserted-by":"publisher","first-page":"101207","DOI":"10.1016\/j.coviro.2022.101207","volume":"53","author":"XY Sun","year":"2022","unstructured":"Sun, X. Y., Ling, Z. Y., Yang, Z. & Sun, B. Broad neutralizing antibody-based strategies to tackle influenza. Curr. Opin. Virol. 53, 101207 (2022).","journal-title":"Curr. Opin. Virol."},{"key":"76731_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.coi.2018.04.001","volume":"53","author":"R Nachbagauer","year":"2018","unstructured":"Nachbagauer, R. & Palese, P. Development of next generation hemagglutinin-based broadly protective influenza virus vaccines. Curr. Opin. Immunol. 53, 51\u201357 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"76731_CR45","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.coviro.2016.03.002","volume":"17","author":"A Cho","year":"2016","unstructured":"Cho, A. & Wrammert, J. Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine. Curr. Opin. Virol. 17, 110\u2013115 (2016).","journal-title":"Curr. Opin. Virol."},{"key":"76731_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/vaccines9020125","volume":"9","author":"M Sangesland","year":"2021","unstructured":"Sangesland, M. & Lingwood, D. Antibody focusing to conserved sites of vulnerability: the immunological pathways for \u2018universal\u2019 influenza vaccines. Vaccines 9, 125 (2021).","journal-title":"Vaccines"},{"key":"76731_CR47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/vaccines9030257","volume":"9","author":"BL Bullard","year":"2021","unstructured":"Bullard, B. L. & Weaver, E. A. Strategies targeting hemagglutinin as a universal influenza vaccine. Vaccines 9, 257 (2021).","journal-title":"Vaccines"},{"key":"76731_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coi.2016.05.012","volume":"42","author":"KE Neu","year":"2016","unstructured":"Neu, K. E., Dunand, C. J. H. & Wilson, P. C. Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?. Curr. Opin. Immunol. 42, 48\u201355 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"76731_CR49","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/14760584.2020.1777861","volume":"19","author":"NMC De Jong","year":"2020","unstructured":"De Jong, N. M. C., Aartse, A., Van Gils, M. J. & Eggink, D. Development of broadly reactive influenza vaccines by targeting the conserved regions of the hemagglutinin stem and head domains. Expert Rev. Vaccines 19, 563\u2013577 (2020).","journal-title":"Expert Rev. Vaccines"},{"key":"76731_CR50","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-med-120617-041310","volume":"71","author":"R Nachbagauer","year":"2020","unstructured":"Nachbagauer, R. & Palese, P. Is a universal influenza virus vaccine possible?. Annu. Rev. Med. 71, 315\u2013327 (2020).","journal-title":"Annu. Rev. Med."},{"key":"76731_CR51","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1128\/JVI.00137-12","volume":"86","author":"R Hai","year":"2012","unstructured":"Hai, R. et al. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J. Virol. 86, 5774\u20135781 (2012).","journal-title":"J. Virol."},{"key":"76731_CR52","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.1128\/JVI.00641-13","volume":"87","author":"F Krammer","year":"2013","unstructured":"Krammer, F., Pica, N., Hai, R., Margine, I. & Palese, P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J. Virol. 87, 6542\u20136550 (2013).","journal-title":"J. Virol."},{"key":"76731_CR53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","volume":"27","author":"R Nachbagauer","year":"2021","unstructured":"Nachbagauer, R. et al. A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial. Nat. Med. 27, 106\u2013114 (2021).","journal-title":"Nat. Med."},{"key":"76731_CR54","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1128\/JVI.03152-15","volume":"90","author":"DM Carter","year":"2016","unstructured":"Carter, D. M. et al. Design and characterization of a computationally optimized broadly reactive hemagglutinin vaccine for H1N1 influenza viruses. J. Virol. 90, 4720\u20134734 (2016).","journal-title":"J. Virol."},{"key":"76731_CR55","first-page":"e01526","volume":"95","author":"ZB Reneer","year":"2021","unstructured":"Reneer, Z. B., Jamieson, P. J., Skarlupka, A. L., Huang, Y. & Ross, T. M. Computationally optimized broadly reactive H2 HA influenza vaccines elicited broadly cross-reactive antibodies and protected mice from viral challenges. J. Virol. 95, e01526\u201320 (2021).","journal-title":"J. Virol."},{"key":"76731_CR56","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01581-17","volume":"91","author":"TM Wong","year":"2017","unstructured":"Wong, T. M. et al. Computationally optimized broadly reactive hemagglutinin elicits hemagglutination inhibition antibodies against a panel of H3N2 influenza virus cocirculating variants. J. Virol. 91, e01581-17 (2017).","journal-title":"J. Virol."},{"key":"76731_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00018-10","volume":"1","author":"J Steel","year":"2010","unstructured":"Steel, J. et al. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. mBio 1, e00018-10 (2010).","journal-title":"mBio"},{"key":"76731_CR58","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1126\/science.aac7263","volume":"349","author":"A Impagliazzo","year":"2015","unstructured":"Impagliazzo, A. et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science 349, 1301\u20131306 (2015).","journal-title":"Science"},{"key":"76731_CR59","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02810-18","volume":"10","author":"KS Corbett","year":"2019","unstructured":"Corbett, K. S. et al. Design of nanoparticulate group 2 influenza virus hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages. mBio 10, e02810-18 (2019).","journal-title":"mBio"},{"key":"76731_CR60","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm.3927","volume":"21","author":"HM Yassine","year":"2015","unstructured":"Yassine, H. M. et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat. Med. 21, 1065\u20131070 (2015).","journal-title":"Nat. Med."},{"key":"76731_CR61","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","volume":"499","author":"M Kanekiyo","year":"2013","unstructured":"Kanekiyo, M. et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499, 102\u2013106 (2013).","journal-title":"Nature"},{"key":"76731_CR62","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41590-018-0305-x","volume":"20","author":"M Kanekiyo","year":"2019","unstructured":"Kanekiyo, M. et al. Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses. Nat. Immunol. 20, 362\u2013372 (2019).","journal-title":"Nat. Immunol."},{"key":"76731_CR63","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","volume":"592","author":"S Boyoglu-Barnum","year":"2021","unstructured":"Boyoglu-Barnum, S. et al. Quadrivalent influenza nanoparticle vaccines induce broad protection. Nature 592, 623\u2013628 (2021).","journal-title":"Nature"},{"key":"76731_CR64","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.3390\/ijms25137259","volume":"25","author":"H Ren","year":"2024","unstructured":"Ren, H. et al. Self-assembling nanoparticle hemagglutinin influenza vaccines induce high antibody response. Int. J. Mol. Sci. 25, 7259 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"76731_CR65","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41591-021-01660-8","volume":"28","author":"KV Houser","year":"2022","unstructured":"Houser, K. V. et al. Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial. Nat. Med. 28, 383\u2013391 (2022).","journal-title":"Nat. Med."},{"key":"76731_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00959-0","volume":"9","author":"JP Casazza","year":"2024","unstructured":"Casazza, J. P. et al. Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine. Npj Vaccines 9, 171 (2024).","journal-title":"Npj Vaccines"},{"key":"76731_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade4976","volume":"15","author":"SF Andrews","year":"2023","unstructured":"Andrews, S. F. et al. An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans. Sci. Transl. Med. 15, eade4976 (2023).","journal-title":"Sci. Transl. Med."},{"key":"76731_CR68","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade4790","volume":"15","author":"AT Widge","year":"2023","unstructured":"Widge, A. T. et al. An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults. Sci. Transl. Med. 15, eade4790 (2023).","journal-title":"Sci. Transl. Med."},{"key":"76731_CR69","doi-asserted-by":"publisher","first-page":"777095","DOI":"10.3389\/fmolb.2021.777095","volume":"8","author":"M Caffrey","year":"2021","unstructured":"Caffrey, M. & Lavie, A. pH-dependent mechanisms of influenza infection mediated by hemagglutinin. Front. Mol. Biosci. 8, 777095 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"76731_CR70","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.bpj.2016.04.035","volume":"110","author":"S Di Lella","year":"2016","unstructured":"Di Lella, S., Herrmann, A. & Mair, C. M. Modulation of the pH stability of influenza virus hemagglutinin: a host cell adaptation strategy. Biophys. J. 110, 2293\u20132301 (2016).","journal-title":"Biophys. J."},{"key":"76731_CR71","unstructured":"Russell, C. J. in Influenza Pathogenesis and Control Vol I, Vol. 385 (eds Compans, R. W. and Oldstone, M. B. A.) 93\u2013116 (Springer, 2014)."},{"key":"76731_CR72","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1128\/JVI.00808-15","volume":"89","author":"PS Lee","year":"2015","unstructured":"Lee, P. S., Zhu, X. Y., Yu, W. L. & Wilson, I. A. Design and structure of an engineered disulfide-stabilized influenza virus hemagglutinin trimer. J. Virol. 89, 7417\u20137420 (2015).","journal-title":"J. Virol."},{"key":"76731_CR73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2115379119","volume":"119","author":"FJ Milder","year":"2022","unstructured":"Milder, F. J. et al. Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions. Proc. Natl. Acad. Sci. USA 119, e2115379119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76731_CR74","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1128\/JVI.00057-15","volume":"89","author":"L Byrd-Leotis","year":"2015","unstructured":"Byrd-Leotis, L., Galloway, S. E., Agbogu, E. & Steinhauer, D. A. Influenza hemagglutinin (HA) stem region mutations that stabilize or destabilize the structure of multiple HA subtypes. J. Virol. 89, 4504\u20134516 (2015).","journal-title":"J. Virol."},{"key":"76731_CR75","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrm1076","volume":"4","author":"PM Colman","year":"2003","unstructured":"Colman, P. M. & Lawrence, M. C. The structural biology of type I viral membrane fusion. Nat. Rev. Mol. Cell Biol. 4, 309\u2013319 (2003).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"76731_CR76","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/nsmb.1456","volume":"15","author":"SC Harrison","year":"2008","unstructured":"Harrison, S. C. Viral membrane fusion. Nat. Struct. Mol. Biol. 15, 690\u2013698 (2008).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"76731_CR77","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/10409230802058320","volume":"43","author":"JM White","year":"2008","unstructured":"White, J. M., Delos, S. E., Brecher, M. & Schornberg, K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 43, 189\u2013219 (2008).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"76731_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37742-z","volume":"14","author":"Y-N Zhang","year":"2023","unstructured":"Zhang, Y.-N. et al. Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimers as HIV-1 vaccine candidates. Nat. Commun. 14, 1985 (2023).","journal-title":"Nat. Commun."},{"key":"76731_CR79","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aau6769","volume":"4","author":"L He","year":"2018","unstructured":"He, L. et al. HIV-1 vaccine design through minimizing envelope metastability. Sci. Adv. 4, eaau6769 (2018).","journal-title":"Sci. Adv."},{"key":"76731_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12040","volume":"7","author":"L Kong","year":"2016","unstructured":"Kong, L. et al. Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability. Nat. Commun. 7, 12040 (2016).","journal-title":"Nat. Commun."},{"key":"76731_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12041","volume":"7","author":"L He","year":"2016","unstructured":"He, L. et al. Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles. Nat. Commun. 7, 12041 (2016).","journal-title":"Nat. Commun."},{"key":"76731_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-66367-7","volume":"16","author":"Y-Z Lee","year":"2025","unstructured":"Lee, Y.-Z. et al. Rational design of next-generation filovirus vaccines combining glycoprotein stabilization and nanoparticle display with glycan modification. Nat. Commun. 16, 11368 (2025).","journal-title":"Nat. Commun."},{"key":"76731_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22867-w","volume":"12","author":"L He","year":"2021","unstructured":"He, L. et al. Single-component multilayered self-assembling nanoparticles presenting rationally designed glycoprotein trimers as Ebola virus vaccines. Nat. Commun. 12, 2633 (2021).","journal-title":"Nat. Commun."},{"key":"76731_CR84","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj3107","volume":"7","author":"Y-N Zhang","year":"2021","unstructured":"Zhang, Y.-N. et al. Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants. Sci. Adv. 7, eabj3107 (2021).","journal-title":"Sci. Adv."},{"key":"76731_CR85","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf1591","volume":"7","author":"L He","year":"2021","unstructured":"He, L. et al. Single-component, self-assembling, protien nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates. Sci. Adv. 7, eabf1591 (2021).","journal-title":"Sci. Adv."},{"key":"76731_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54287-x","volume":"15","author":"YZ Lee","year":"2024","unstructured":"Lee, Y. Z. et al. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat. Commun. 15, 9939 (2024).","journal-title":"Nat. Commun."},{"key":"76731_CR87","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.1176225","volume":"325","author":"RJ Garten","year":"2009","unstructured":"Garten, R. J. et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325, 197\u2013201 (2009).","journal-title":"Science"},{"key":"76731_CR88","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1128\/JVI.06322-11","volume":"86","author":"R Xu","year":"2012","unstructured":"Xu, R., McBride, R., Nycholat, C. M., Paulson, J. C. & Wilson, I. A. Structural characterization of the hemagglutinin receptor specificity from the 2009 H1N1 influenza pandemic. J. Virol. 86, 982\u2013990 (2012).","journal-title":"J. Virol."},{"key":"76731_CR89","doi-asserted-by":"publisher","first-page":"RRN1152","DOI":"10.1371\/currents.RRN1152","volume":"2","author":"H Yang","year":"2010","unstructured":"Yang, H., Carney, P. & Stevens, J. Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr. 2, RRN1152 (2010).","journal-title":"PLoS Curr."},{"key":"76731_CR90","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s13238-010-0059-1","volume":"1","author":"W Zhang","year":"2010","unstructured":"Zhang, W. et al. Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus. Protein Cell 1, 459\u2013467 (2010).","journal-title":"Protein Cell"},{"key":"76731_CR91","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41586-020-2333-6","volume":"583","author":"DJ Benton","year":"2020","unstructured":"Benton, D. J., Gamblin, S. J., Rosenthal, P. B. & Skehel, J. J. Structural transitions in influenza haemagglutinin at membrane fusion pH. Nature 583, 150\u2013153 (2020).","journal-title":"Nature"},{"key":"76731_CR92","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz8822","volume":"6","author":"MA Benhaim","year":"2020","unstructured":"Benhaim, M. A., Prasad, V. M., Garcia, N. K., Guttman, M. & Lee, K. K. Structural monitoring of a transient intermediate in the hemagglutinin fusion machinery on influenza virions. Sci. Adv. 6, eaaz8822 (2020).","journal-title":"Sci. Adv."},{"key":"76731_CR93","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-024-07766-6","volume":"633","author":"AJ Eisfeld","year":"2024","unstructured":"Eisfeld, A. J. et al. Pathogenicity and transmissibility of bovine H5N1 influenza virus. Nature 633, 426\u2013432 (2024).","journal-title":"Nature"},{"key":"76731_CR94","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-024-07849-4","volume":"634","author":"LC Caserta","year":"2024","unstructured":"Caserta, L. C. et al. Spillover of highly pathogenic avian influenza H5N1 virus to dairy cattle. Nature 634, 669\u2013676 (2024).","journal-title":"Nature"},{"key":"76731_CR95","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3201\/eid3007.240508","volume":"30","author":"ER Burrough","year":"2024","unstructured":"Burrough, E. R. et al. Highly pathogenic avian influenza A(H5N1) clade 2.3.4.4b virus infection in domestic dairy cattle and cats, United States, 2024. Emerg. Infect. Dis. 30, 1335\u20131343 (2024).","journal-title":"Emerg. Infect. Dis."},{"key":"76731_CR96","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1128\/JVI.79.4.2191-2198.2005","volume":"79","author":"EA Govorkova","year":"2005","unstructured":"Govorkova, E. A. et al. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J. Virol. 79, 2191\u20132198 (2005).","journal-title":"J. Virol."},{"key":"76731_CR97","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1126\/science.1171491","volume":"324","author":"DC Ekiert","year":"2009","unstructured":"Ekiert, D. C. et al. Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246\u2013251 (2009).","journal-title":"Science"},{"key":"76731_CR98","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nsmb.1566","volume":"16","author":"JH Sui","year":"2009","unstructured":"Sui, J. H. et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265\u2013273 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"76731_CR99","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/vaccines12090975","volume":"12","author":"YN Zhang","year":"2024","unstructured":"Zhang, Y.-N. et al. A single-component multilayered self-assembling protein nanoparticle vaccine based on extracellular domains of matrix protein 2 against both influenza A and B. Vaccines 12, 975 (2024).","journal-title":"Vaccines"},{"key":"76731_CR100","doi-asserted-by":"publisher","first-page":"23545","DOI":"10.1021\/acsnano.3c06526","volume":"17","author":"K Braz Gomes","year":"2023","unstructured":"Braz Gomes, K. et al. Single-component multilayered self-assembling protein nanoparticles displaying extracellular domains of matrix protein 2 as a pan-influenza A vaccine. ACS Nano 17, 23545\u201323567 (2023).","journal-title":"ACS Nano"},{"key":"76731_CR101","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz6225","volume":"6","author":"L He","year":"2020","unstructured":"He, L. et al. Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines. Sci. Adv. 6, eaaz6225 (2020).","journal-title":"Sci. Adv."},{"key":"76731_CR102","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1126\/science.1186430","volume":"328","author":"R Xu","year":"2010","unstructured":"Xu, R. et al. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328, 357\u2013360 (2010).","journal-title":"Science"},{"key":"76731_CR103","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12985-019-1188-7","volume":"16","author":"QY Zhuang","year":"2019","unstructured":"Zhuang, Q. Y. et al. Diversity and distribution of type A influenza viruses: an updated panorama analysis based on protein sequences. Virol. J. 16, 85 (2019).","journal-title":"Virol. J."},{"key":"76731_CR104","doi-asserted-by":"crossref","unstructured":"Yoon, S. W., Webby, R. J. & Webster, R. G. in Influenza Pathogenesis and Control\u2014Vol I, Vol. 385 (eds Compans, R. W. and Oldstone, M. B. A.) 359\u2013375 (Springer, 2014).","DOI":"10.1007\/82_2014_396"},{"key":"76731_CR105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009566","volume":"17","author":"J West","year":"2021","unstructured":"West, J. et al. Characterization of changes in the hemagglutinin that accompanied the emergence of H3N2\/1968 pandemic influenza viruses. PLoS Pathog. 17, e1009566 (2021).","journal-title":"PLoS Pathog."},{"key":"76731_CR106","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1126\/science.1154137","volume":"320","author":"CA Russell","year":"2008","unstructured":"Russell, C. A. et al. The global circulation of seasonal influenza A (H3N2) viruses. Science 320, 340\u2013346 (2008).","journal-title":"Science"},{"key":"76731_CR107","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.tim.2017.06.008","volume":"25","author":"S Su","year":"2017","unstructured":"Su, S. et al. Epidemiology, evolution, and pathogenesis of H7N9 influenza viruses in five epidemic waves since 2013 in China. Trends Microbiol. 25, 713\u2013728 (2017).","journal-title":"Trends Microbiol."},{"key":"76731_CR108","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.tim.2014.08.008","volume":"22","author":"T Watanabe","year":"2014","unstructured":"Watanabe, T., Watanabe, S., Maher, E. A., Neumann, G. & Kawaoka, Y. Pandemic potential of avian influenza A (H7N9) viruses. Trends Microbiol. 22, 623\u2013631 (2014).","journal-title":"Trends Microbiol."},{"key":"76731_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14579-4","volume":"11","author":"S Boyoglu-Barnum","year":"2020","unstructured":"Boyoglu-Barnum, S. et al. Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses. Nat. Commun. 11, 791 (2020).","journal-title":"Nat. Commun."},{"key":"76731_CR110","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.bbamem.2013.10.004","volume":"1838","author":"CM Mair","year":"2014","unstructured":"Mair, C. M., Ludwig, K., Herrmann, A. & Sieben, C. Receptor binding and pH stability\u2014how influenza A virus hemagglutinin affects host-specific virus infection. Biochim. Biophys. Acta 1838, 1153\u20131168 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"76731_CR111","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/v13050746","volume":"13","author":"CJ Russell","year":"2021","unstructured":"Russell, C. J. Hemagglutinin stability and its impact on influenza A virus infectivity, pathogenicity, and transmissibility in avians, mice, swine, seals, ferrets, and humans. Viruses 13, 746 (2021).","journal-title":"Viruses"},{"key":"76731_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003151","volume":"9","author":"SE Galloway","year":"2013","unstructured":"Galloway, S. E., Reed, M. L., Russell, C. J. & Steinhauer, D. A. Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation. PLoS Pathog. 9, e1003151 (2013).","journal-title":"PLoS Pathog."},{"key":"76731_CR113","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.1073\/pnas.111165798","volume":"98","author":"EG Brown","year":"2001","unstructured":"Brown, E. G., Liu, H., Kit, L. C., Baird, S. & Nesrallah, M. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc. Natl. Acad. Sci. USA 98, 6883\u20136888 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76731_CR114","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00375-18","volume":"92","author":"H Yang","year":"2018","unstructured":"Yang, H., Carney, P. J., Chang, J. C., Guo, Z. & Stevens, J. Structural and molecular characterization of the hemagglutinin from the fifth-epidemic-wave A(H7N9) influenza viruses. J. Virol. 92, e00375-18 (2018).","journal-title":"J. Virol."},{"key":"76731_CR115","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nature11414","volume":"489","author":"DC Ekiert","year":"2012","unstructured":"Ekiert, D. C. et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489, 526\u2013532 (2012).","journal-title":"Nature"},{"key":"76731_CR116","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1126\/science.1243761","volume":"342","author":"R Xu","year":"2013","unstructured":"Xu, R. et al. Preferential recognition of avian-like receptors in human influenza A H7N9 viruses. Science 342, 1230\u20131235 (2013).","journal-title":"Science"},{"key":"76731_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4614","volume":"5","author":"PS Lee","year":"2014","unstructured":"Lee, P. S. et al. Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus. Nat. Commun. 5, 3614 (2014).","journal-title":"Nat. Commun."},{"key":"76731_CR118","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337, 1343\u20131348 (2012).","journal-title":"Science"},{"key":"76731_CR119","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","volume":"177","author":"S Bangaru","year":"2019","unstructured":"Bangaru, S. et al. A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface. Cell 177, 1136\u20131152.e1118 (2019).","journal-title":"Cell"},{"key":"76731_CR120","doi-asserted-by":"publisher","first-page":"104970","DOI":"10.1016\/j.antiviral.2020.104970","volume":"185","author":"H Zaraket","year":"2021","unstructured":"Zaraket, H., Hurt, A. C., Clinch, B., Barr, I. & Lee, N. Burden of influenza B virus infection and considerations for clinical management. Antivir. Res. 185, 104970 (2021).","journal-title":"Antivir. Res."},{"key":"76731_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-69418-9","volume":"17","author":"L He","year":"2026","unstructured":"He, L. et al. Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design. Nat. Commun. 17, 2633 (2026).","journal-title":"Nat. Commun."},{"key":"76731_CR122","doi-asserted-by":"publisher","first-page":"17040","DOI":"10.1073\/pnas.1212371109","volume":"109","author":"PS Lee","year":"2012","unstructured":"Lee, P. S. et al. Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity. Proc. Natl. Acad. Sci. USA 109, 17040\u201317045 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76731_CR123","doi-asserted-by":"publisher","first-page":"12619","DOI":"10.1128\/JVI.01577-13","volume":"87","author":"XY Zhu","year":"2013","unstructured":"Zhu, X. Y. et al. A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A\/Goose\/Guangdong\/1\/96 hemagglutinin. J. Virol. 87, 12619\u201312635 (2013).","journal-title":"J. Virol."},{"key":"76731_CR124","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","volume":"166","author":"MG Joyce","year":"2016","unstructured":"Joyce, M. G. et al. Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses. Cell 166, 609\u2013623 (2016).","journal-title":"Cell"},{"key":"76731_CR125","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau2710","volume":"4","author":"K Matsuda","year":"2019","unstructured":"Matsuda, K. et al. Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine. Sci. Immunol. 4, eaau2710 (2019).","journal-title":"Sci. Immunol."},{"key":"76731_CR126","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","volume":"166","author":"NL Kallewaard","year":"2016","unstructured":"Kallewaard, N. L. et al. Structure and function analysis of an antibody recognizing all influenza A subtypes. Cell 166, 596\u2013608 (2016).","journal-title":"Cell"},{"key":"76731_CR127","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1204839","volume":"333","author":"DC Ekiert","year":"2011","unstructured":"Ekiert, D. C. et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333, 843\u2013850 (2011).","journal-title":"Science"},{"key":"76731_CR128","doi-asserted-by":"publisher","first-page":"1049134","DOI":"10.3389\/fviro.2022.1049134","volume":"2","author":"AL Beukenhorst","year":"2022","unstructured":"Beukenhorst, A. L. et al. The influenza hemagglutinin stem antibody CR9114: evidence for a narrow evolutionary path towards universal protection. Front. Virol. 2, 1049134 (2022).","journal-title":"Front. Virol."},{"key":"76731_CR129","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850\u2013856 (2011).","journal-title":"Science"},{"key":"76731_CR130","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/v6031294","volume":"6","author":"MD Tate","year":"2014","unstructured":"Tate, M. D. et al. Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. Viruses 6, 1294\u20131316 (2014).","journal-title":"Viruses"},{"key":"76731_CR131","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","volume":"19","author":"CJ Wei","year":"2020","unstructured":"Wei, C. J. et al. Next-generation influenza vaccines: opportunities and challenges. Nat. Rev. Drug Discov. 19, 239\u2013252 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"76731_CR132","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fimmu.2019.00022","volume":"10","author":"S Al-Halifa","year":"2019","unstructured":"Al-Halifa, S., Gauthier, L., Arpin, D., Bourgault, S. & Archambault, D. Nanoparticle-based vaccines against respiratory viruses. Front. Immunol. 10, 22 (2019).","journal-title":"Front. Immunol."},{"key":"76731_CR133","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1080\/14760584.2018.1541408","volume":"17","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Deng, L., Kang, S. M. & Wang, B. Z. Universal influenza vaccines: from viruses to nanoparticles. Expert Rev. Vaccines 17, 967\u2013976 (2018).","journal-title":"Expert Rev. Vaccines"},{"key":"76731_CR134","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat4615","volume":"10","author":"R Rappuoli","year":"2018","unstructured":"Rappuoli, R. Glycoconjugate vaccines: principles and mechanisms. Sci. Transl. Med. 10, eaat4615 (2018).","journal-title":"Sci. Transl. Med."},{"key":"76731_CR135","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ni.1946","volume":"11","author":"JG Cyster","year":"2010","unstructured":"Cyster, J. G. B cell follicles and antigen encounters of the third kind. Nat. Immunol. 11, 989\u2013996 (2010).","journal-title":"Nat. Immunol."},{"key":"76731_CR136","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nri3689","volume":"14","author":"BA Heesters","year":"2014","unstructured":"Heesters, B. A., Myers, R. C. & Carroll, M. C. Follicular dendritic cells: dynamic antigen libraries. Nat. Rev. Immunol. 14, 495\u2013504 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"76731_CR137","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.immuni.2024.06.009","volume":"57","author":"JG Cyster","year":"2024","unstructured":"Cyster, J. G. & Wilson, P. C. Antibody modulation of B cell responses-Incorporating positive and negative feedback. Immunity 57, 1466\u20131481 (2024).","journal-title":"Immunity"},{"key":"76731_CR138","doi-asserted-by":"publisher","first-page":"7226","DOI":"10.1021\/acs.nanolett.9b02834","volume":"19","author":"YN Zhang","year":"2019","unstructured":"Zhang, Y.-N. et al. Nanoparticle size influences antigen retention and presentation in lymph node follicles for humoral immunity. Nano Lett. 19, 7226\u20137235 (2019).","journal-title":"Nano Lett."},{"key":"76731_CR139","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acsnano.0c02240","volume":"14","author":"YN Zhang","year":"2020","unstructured":"Zhang, Y.-N., Poon, W., Sefton, E. & Chan, W. C. W. Suppressing subcapsular sinus macrophages enhances transport of nanovaccines to lymph node follicles for robust humoral immunity. ACS Nano 14, 9478\u20139490 (2020).","journal-title":"ACS Nano"},{"key":"76731_CR140","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.it.2010.03.002","volume":"31","author":"ME El Shikh","year":"2010","unstructured":"El Shikh, M. E., El Sayed, R. M., Sukumar, S., Szakal, A. K. & Tew, J. G. Activation of B cells by antigens on follicular dendritic cells. Trends Immunol. 31, 205\u2013211 (2010).","journal-title":"Trends Immunol."},{"key":"76731_CR141","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1586\/14760584.6.5.699","volume":"6","author":"DT O\u2019Hagan","year":"2007","unstructured":"O\u2019Hagan, D. T. MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection. Expert Rev. Vaccines 6, 699\u2013710 (2007).","journal-title":"Expert Rev. Vaccines"},{"key":"76731_CR142","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.immuni.2007.06.007","volume":"27","author":"YR Carrasco","year":"2007","unstructured":"Carrasco, Y. R. & Batista, F. D. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity 27, 160\u2013171 (2007).","journal-title":"Immunity"},{"key":"76731_CR143","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature06287","volume":"450","author":"T Junt","year":"2007","unstructured":"Junt, T. et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450, 110\u2013114 (2007).","journal-title":"Nature"},{"key":"76731_CR144","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/ni.1745","volume":"10","author":"TG Phan","year":"2009","unstructured":"Phan, T. G., Green, J. A., Gray, E. E., Xu, Y. & Cyster, J. G. Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat. Immunol. 10, 786\u2013793 (2009).","journal-title":"Nat. Immunol."},{"key":"76731_CR145","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/ni.1856","volume":"11","author":"SF Gonzalez","year":"2010","unstructured":"Gonzalez, S. F. et al. Capture of influenza by medullary dendritic cells via SIGN-R1 is essential for humoral immunity in draining lymph nodes. Nat. Immunol. 11, 427\u2013434 (2010).","journal-title":"Nat. Immunol."},{"key":"76731_CR146","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","volume":"30","author":"GD Victora","year":"2012","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 30, 429\u2013457 (2012).","journal-title":"Annu. Rev. Immunol."},{"key":"76731_CR147","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.immuni.2007.07.009","volume":"27","author":"CD Allen","year":"2007","unstructured":"Allen, C. D., Okada, T. & Cyster, J. G. Germinal-center organization and cellular dynamics. Immunity 27, 190\u2013202 (2007).","journal-title":"Immunity"},{"key":"76731_CR148","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.1241680","volume":"341","author":"Z Shulman","year":"2013","unstructured":"Shulman, Z. et al. T follicular helper cell dynamics in germinal centers. Science 341, 673\u2013677 (2013).","journal-title":"Science"},{"key":"76731_CR149","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","volume":"41","author":"S Crotty","year":"2014","unstructured":"Crotty, S. T follicular helper cell differentiation, function, and roles in disease. Immunity 41, 529\u2013542 (2014).","journal-title":"Immunity"},{"key":"76731_CR150","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3390\/v13040546","volume":"13","author":"KA Nagashima","year":"2021","unstructured":"Nagashima, K. A. & Mousa, J. J. Next-generation influenza HA immunogens and adjuvants in pursuit of a broadly protective vaccine. Viruses 13, 546 (2021).","journal-title":"Viruses"},{"key":"76731_CR151","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/vaccines9010026","volume":"9","author":"CLD McMillan","year":"2021","unstructured":"McMillan, C. L. D., Young, P. R., Watterson, D. & Chappell, K. J. The next generation of influenza vaccines: towards a universal solution. Vaccines 9, 26 (2021).","journal-title":"Vaccines"},{"key":"76731_CR152","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12250-020-00283-6","volume":"36","author":"RK Du","year":"2021","unstructured":"Du, R. K., Cui, Q. H. & Rong, L. J. Flu universal vaccines: new tricks on an old virus. Virol. Sin. 36, 13\u201324 (2021).","journal-title":"Virol. Sin."},{"key":"76731_CR153","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1093\/infdis\/jiz017","volume":"219","author":"MC Eichelberger","year":"2019","unstructured":"Eichelberger, M. C. & Monto, A. S. Neuraminidase, the forgotten surface antigen, emerges as an influenza vaccine target for broadened protection. J. Infect. Dis. 219, S75\u2013S80 (2019).","journal-title":"J. Infect. Dis."},{"key":"76731_CR154","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02332-17","volume":"9","author":"F Krammer","year":"2018","unstructured":"Krammer, F. et al. NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines?. mBio 9, e02332-17 (2018).","journal-title":"mBio"},{"key":"76731_CR155","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.coi.2018.03.025","volume":"53","author":"MC Eichelberger","year":"2018","unstructured":"Eichelberger, M. C., Morens, D. M. & Taubenberger, J. K. Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness. Curr. Opin. Immunol. 53, 38\u201344 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"76731_CR156","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm0899","volume":"14","author":"HY Huang","year":"2022","unstructured":"Huang, H. Y. et al. Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models. Sci. Transl. Med. 14, eabm0899 (2022).","journal-title":"Sci. Transl. Med."},{"key":"76731_CR157","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1073\/pnas.1323954111","volume":"111","author":"JR Chen","year":"2014","unstructured":"Chen, J. R. et al. Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections. Proc. Natl. Acad. Sci. USA 111, 2476\u20132481 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76731_CR158","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.jip.2011.05.003","volume":"107","author":"MMJ Cox","year":"2011","unstructured":"Cox, M. M. J. & Hashimoto, Y. A fast track influenza virus vaccine produced in insect cells. J. Invertebr. Pathol. 107, S31\u2013S41 (2011).","journal-title":"J. Invertebr. Pathol."},{"key":"76731_CR159","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/vaccines10020148","volume":"10","author":"G Keresztes","year":"2022","unstructured":"Keresztes, G. et al. The highly productive thermothelomyces heterothallica C1 expression system as a host for rapid development of influenza vaccines. Vaccines 10, 148 (2022).","journal-title":"Vaccines"},{"key":"76731_CR160","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1128\/JVI.00959-08","volume":"82","author":"XJ Xu","year":"2008","unstructured":"Xu, X. J., Zhu, X. Y., Dwek, R. A., Stevens, J. & Wilson, I. A. Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J. Virol. 82, 10493\u201310501 (2008).","journal-title":"J. Virol."},{"key":"76731_CR161","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Method Enzymol. 276, 307\u2013326 (1997).","journal-title":"Method Enzymol."},{"key":"76731_CR162","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1107\/S0907444905001617","volume":"61","author":"AJ McCoy","year":"2005","unstructured":"McCoy, A. J., Grosse-Kunstleve, R. W., Storoni, L. C. & Read, R. J. Likelihood-enhanced fast translation functions. Acta Crystallogr. Sect. D Struct. Biol. 61, 458\u2013464 (2005).","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"76731_CR163","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1107\/S0907444996012255","volume":"53","author":"GN Murshudov","year":"1997","unstructured":"Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. Sect. D Struct. Biol. 53, 240\u2013255 (1997).","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"76731_CR164","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D. Struct. Biol. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. Sect. D. Struct. Biol."},{"key":"76731_CR165","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"76731_CR166","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. Sect. D Struct. Biol. 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr. Sect. D Struct. Biol."},{"key":"76731_CR167","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","volume":"157","author":"G Tang","year":"2007","unstructured":"Tang, G. et al. EMAN2: an extensible image processing suite for electron microscopy. J. Struct. Biol. 157, 38\u201346 (2007).","journal-title":"J. Struct. Biol."},{"key":"76731_CR168","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"76731_CR169","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF chimera\u2014a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"76731_CR170","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4792","volume":"32","author":"EC Meng","year":"2023","unstructured":"Meng, E. C. et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 32, e4792 (2023).","journal-title":"Protein Sci."},{"key":"76731_CR171","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","volume":"5","author":"MA Ramakrishnan","year":"2016","unstructured":"Ramakrishnan, M. A. Determination of 50% endpoint titer using a simple formula. World J. Virol. 5, 85\u201386 (2016).","journal-title":"World J. Virol."},{"key":"76731_CR172","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"76731_CR173","unstructured":"World Health Organization. Manual for the Laboratory Diagnosis and Virological Surveillance Of Influenza. https:\/\/iris.who.int\/handle\/10665\/44518 (World Health Organization, 2011)."},{"key":"76731_CR174","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1586\/eri.11.51","volume":"9","author":"JM Katz","year":"2011","unstructured":"Katz, J. M., Hancock, K. & Xu, X. Y. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev. Anti Infect. Ther. 9, 669\u2013683 (2011).","journal-title":"Expert Rev. Anti Infect. Ther."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76731-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76731-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76731-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:04:06Z","timestamp":1789124646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76731-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":174,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76731"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76731-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.Z. serves as the Co-Founder of Uvax Bio, LLC, and holds associated financial interests. Other authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9717"}}